Get measles vaccine to avoid rapid spread, says UK health boss
People have forgotten how miserable it is to have measles, a top health official warns.
Similar Posts
Finding happiness after the Clutha helicopter crash
It’s a decade since a police helicopter crashed through the roof of the Clutha Bar in Glasgow. Among those there that Friday night was Michael Byrne. He helped pull survivors from the rubble at the city centre bar, where 10 people lost their lives. Although Michael managed to escape without injury, the emotional impact the…
Footballer Michael Owen on sight loss: 'I'd swap eyes with my son if I could'
The father and son on getting to grips with a degenerative eye condition.
Johnson & Johnson to settle talc baby powder probe
Containers of Johnson and Johnson baby powder are displayed on a Walgreens shelf on April 05, 2023 in San Anselmo, California. Justin Sullivan | Getty Images Johnson & Johnson has reached a tentative settlement to resolve an investigation by more than 40 states into whether the company misled patients about the safety of its talc…
Pharma had a year full of firsts
Soumyabrata Roy | Nurphoto | Getty Images Drugmakers are closing out a year when they achieved several historic firsts that will shape the pharmaceutical industry in 2024 and beyond. The weight loss drug market transformed into the pharmaceutical industry’s newest gold rush this year, as demand for costly but highly effective treatments from Novo Nordisk…
Sunak reveals he fasts at the beginning of the week
The PM has said he tries to fast at the start of the week so he can indulge in his “weakness for sugary things” on other days. Rishi Sunak told the BBC’s health editor Hugh Pym it was an “important discipline” for him, as he also spoke about the government’s clampdown on disposable vapes. Rishi…
Big pharma Merck, Bristol Myers, J&J prepare to lose revenue
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSE Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a looming threat that will put tens of billions of dollars in sales at risk between now and 2030, as blockbuster drugs will tumble off a…